Harrabi, H.; Mamona-Kilu, C.; Meyer, E.; d’Anglejan Chatillon, E.; Dournon, N.; Bouchand, F.; Duran, C.; Perronne, V.; Jaffal, K.; Dinh, A.
Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence. Antibiotics 2025, 14, 1066.
https://doi.org/10.3390/antibiotics14111066
AMA Style
Harrabi H, Mamona-Kilu C, Meyer E, d’Anglejan Chatillon E, Dournon N, Bouchand F, Duran C, Perronne V, Jaffal K, Dinh A.
Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence. Antibiotics. 2025; 14(11):1066.
https://doi.org/10.3390/antibiotics14111066
Chicago/Turabian Style
Harrabi, Hajer, Christel Mamona-Kilu, Eloïse Meyer, Emma d’Anglejan Chatillon, Nathalie Dournon, Frédérique Bouchand, Clara Duran, Véronique Perronne, Karim Jaffal, and Aurélien Dinh.
2025. "Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence" Antibiotics 14, no. 11: 1066.
https://doi.org/10.3390/antibiotics14111066
APA Style
Harrabi, H., Mamona-Kilu, C., Meyer, E., d’Anglejan Chatillon, E., Dournon, N., Bouchand, F., Duran, C., Perronne, V., Jaffal, K., & Dinh, A.
(2025). Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence. Antibiotics, 14(11), 1066.
https://doi.org/10.3390/antibiotics14111066
